Your browser doesn't support javascript.
loading
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.
Villar-Prados, Alejandro; Wu, Sherry Y; Court, Karem A; Ma, Shaolin; LaFargue, Christopher; Chowdhury, Mamur A; Engelhardt, Margaret I; Ivan, Cristina; Ram, Prahlad T; Wang, Ying; Baggerly, Keith; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Ming-Yang, Shyh; Maloney, David J; Yoshioka, Makoto; Strovel, Jeffrey W; Roszik, Jason; Sood, Anil K.
Afiliação
  • Villar-Prados A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu SY; School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
  • Court KA; School of Biomedical Sciences, University of Queensland, Queensland, Australia.
  • Ma S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • LaFargue C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chowdhury MA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Engelhardt MI; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ivan C; John P. and Kathrine G. McGovern Medical School, The University of Texas, Houston, Texas.
  • Ram PT; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang Y; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Baggerly K; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rodriguez-Aguayo C; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lopez-Berestein G; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ming-Yang S; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Maloney DJ; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yoshioka M; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Strovel JW; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Roszik J; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sood AK; National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
Mol Cancer Ther ; 18(2): 421-436, 2019 02.
Article em En | MEDLINE | ID: mdl-30420565
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Azepinas / Fatores de Transcrição / Proteínas Nucleares / Receptor Notch3 / Acetamidas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Azepinas / Fatores de Transcrição / Proteínas Nucleares / Receptor Notch3 / Acetamidas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article